dPCR market research provides actionable intelligence on major parameters impacting the market; analyses the market performance of key companies; market dynamics of key segments; outlines the market performance across global regions. The insights of industry over past 5 years and a forecast until 2021 is provided. Report also contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. Industry experts project dPCR market to grow at a CAGR of 10.1% during the period 2017-2021.
Digital polymerase chain reaction (dPCR) technology is an advanced version of the polymerase chain reaction (PCR) technology that enables users to amplify and directly quantify nucleic acids, such as DNA, RNA, cDNA, and methylated DNA with a high level of precision. The technique allows users to statistically analyze PCR products by converting exponential, analog signals obtained from conventional PCR technology to linear and digital signals.
Request a sample of dPCR market research report @ http://www.360marketupdates.com/enquiry/request-sample/10543642
dPCR market potential is analysed for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, demand and present scenarios in dPCR industry. To determine the dPCR market size the report considers detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.The market is divided into the following segments Further the dPCR market report focuses on global major leading industry players with information. Report contains vendor landscape in addition to a SWOT analysis of the key vendors operating in dPCR market space like Bio-Rad Laboratories, Fluidigm, RainDance Technologies, Thermo Fisher Scientific, Becton and many more.
dPCR Market Drivers, and Trends: –
dPCR Market Driver: – One driver in market is demand for high throughput technology. In the last few years, miniaturization of testing systems and automation of technology has increased the throughput by reducing the number of samples required and the duration of time involved in obtaining results. This significantly reduces the wastage of sample, which can be sometimes expensive based on the type of consumables used. The high throughput technology provides more accurate, specific, and efficient data compared with conventional technology. High throughput dPCR technology provides a high degree of accuracy and productivity in genomic and proteomic research. For instance, Bio-Rad Laboratories’ QX200 Droplet Digital PCR (ddPCR) System requires smaller amounts of samples and reagents and provides highly sensitive and precise results.
We even do customized reports for our customers; we can add the list of manufacturers or application type or product types that you need in the report. Ask for it @ http://www.360marketupdates.com/enquiry/pre-order-enquiry/10543642
dPCR Market trend: – One trend in market is rising prominence of PCR solutions in biomedical sector. The biomedical sector has increasingly adopted and applied PCR solutions such as dPCR due to the advantages and benefits regarding their features. For example, dPCR is widely used for pathogen detection and microbiome analysis that require the detection and quantitation of low-abundance microorganisms in complex backgrounds. Further, the increase in the body of knowledge related to disease diagnostics and progressions in technology has led to the development of specialized dPCR solutions to suit the area of research. The rapid growth of the biomedical sector in APAC is likely to boost the adoption of PCR solutions as they find high applicability in this field. Many countries in this region will provide a huge base for clinical trials and drug discovery. In China, Singapore, and South Korea, the governments have taken several measures to support investments in R&D, particularly in the biomedical sector over the next five years